Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables RefundsShares OutstandingShort-Term Debt repayments
Ratios

BioNexus Gene Lab (BGLC) Shares Issued (2018 - 2024)

Historic Shares Issued for BioNexus Gene Lab (BGLC) over the last 3 years, with Q4 2024 value amounting to $1064.0.

  • BioNexus Gene Lab's Shares Issued changed N/A to $1064.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $2650.0, marking a year-over-year increase of 10053.1%. This contributed to the annual value of $79851.0 for FY2024, which is N/A changed from last year.
  • Per BioNexus Gene Lab's latest filing, its Shares Issued stood at $1064.0 for Q4 2024.
  • BioNexus Gene Lab's 5-year Shares Issued high stood at $1586.0 for Q3 2024, and its period low was $1064.0 during Q4 2024.